NCT07365553 Omega-3, Autism Spectrum Disorder (ASD)
| NCT ID | NCT07365553 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China Medical University Hospital |
| Condition | ASD |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2022-07-15 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2022-07-15 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).
Eligibility Criteria
Inclusion Criteria: * diagnosis of DSM5 ASD made by child and adolescent psychiatrist * age 6-17 years-old at the time of enrolment * no pharmacotherapy or non-pharmacotherapy adjustment within the past 4 weeks, * Signed informed consent. Exclusion Criteria: * comorbid other psychiatric disorders, including schizophrenia or affective mood disorder (Bipolar and Major Depressive Disorder), or substance use disorder * comorbid physical disorders, such as thyroid dysfunction, cerebral palsy, coagulation disorders * currently using omega-3 supplements or probiotics * allergy to omega-3.
Contact & Investigator
Pei-Chen Chang, MD, PhD
PRINCIPAL INVESTIGATOR
China Medical University Hospital
Frequently Asked Questions
Who can join the NCT07365553 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying ASD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07365553 currently recruiting?
Yes, NCT07365553 is actively recruiting participants. Contact the research team at d13121@mail.cmuh.org.tw for enrollment information.
Where is the NCT07365553 trial being conducted?
This trial is being conducted at Taichung, Taiwan.
Who is sponsoring the NCT07365553 clinical trial?
NCT07365553 is sponsored by China Medical University Hospital. The principal investigator is Pei-Chen Chang, MD, PhD at China Medical University Hospital. The trial plans to enroll 50 participants.